Lamagna Chrystelle, Meda Paolo, Mandicourt Guillaume, Brown James, Gilbert Robert J C, Jones E Yvonne, Kiefer Friedemann, Ruga Pilar, Imhof Beat A, Aurrand-Lions Michel
Department of Pathology and Immunology, Centre Médical Universitaire, 1204 Geneva, Switzerland.
Mol Biol Cell. 2005 Oct;16(10):4992-5003. doi: 10.1091/mbc.e05-04-0310. Epub 2005 Aug 10.
The junctional adhesion molecules (JAMs) have been recently described as interendothelial junctional molecules and as integrin ligands. Here we show that JAM-B and JAM-C undergo heterophilic interaction in cell-cell contacts and that JAM-C is recruited and stabilized in junctional complexes by JAM-B. In addition, soluble JAM-B dissociates soluble JAM-C homodimers to form JAM-B/JAM-C heterodimers. This suggests that the affinity of JAM-C monomers to form dimers is higher for JAM-B than for JAM-C. Using antibodies against JAM-C, the formation of JAM-B/JAM-C heterodimers can be abolished. This liberates JAM-C from its vascular binding partner JAM-B and makes it available on the apical side of vessels for interaction with its leukocyte counter-receptor alpha(M)beta2 integrin. We demonstrate that the modulation of JAM-C localization in junctional complexes is a new regulatory mechanism for alpha(M)beta2-dependent adhesion of leukocytes.
连接黏附分子(JAMs)最近被描述为内皮细胞间连接分子和整合素配体。在此我们表明,JAM-B和JAM-C在细胞间接触中发生异嗜性相互作用,并且JAM-C被JAM-B募集并稳定在连接复合体中。此外,可溶性JAM-B使可溶性JAM-C同二聚体解离以形成JAM-B/JAM-C异二聚体。这表明JAM-C单体形成二聚体时对JAM-B的亲和力高于对JAM-C的亲和力。使用抗JAM-C抗体可消除JAM-B/JAM-C异二聚体的形成。这使JAM-C从其血管结合伴侣JAM-B中释放出来,并使其在血管顶端可用于与其白细胞反受体α(M)β2整合素相互作用。我们证明,调节JAM-C在连接复合体中的定位是α(M)β2依赖性白细胞黏附的一种新调控机制。